Tiludronate disodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for tiludronate disodium and what is the scope of patent protection?
Tiludronate disodium
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for tiludronate disodium.
Summary for tiludronate disodium
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Patent Applications: | 2,100 |
| DailyMed Link: | tiludronate disodium at DailyMed |
US Patents and Regulatory Information for tiludronate disodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for tiludronate disodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
